Safinamide

CAS No.:133865-89-1

TBW04233
(S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide;2(S)-[4-(3-Fluorobenzyloxy)benzylamino]propionamide;Safinamide;(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;(S)-2-(4-(3-FLUOROBENZYLOXY)BENZYLAMINO)PROPANAMIDE;(2S)-2-[4-(3-fluorobenzyloxy)benzylamino]propionamide;(S)-(+)-2-[4-(3-fluorobenzyloxy)benzylamino]-propanamide;(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propionamide;EMD 1195686;EMD-1195686;FCE 26743;FCE-26743;(4-((3-fluorobenzyl)oxy)benzyl)-L-alanine;Xadago;90ENL74SIG;2(s)-(4-(3-fluorobenzyloxy)benzylamino)propionamide;Safinamide [USAN:INN];2-(4-(3-Fluorobenzyloxy)benzylamino)propionamide;(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide;Safinam
inquiry
C17H19FN2O2
302.34

Product introduction

Category: Drug Impurities and Intermediates
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: FC1=C([H])C([H])=C([H])C(=C1[H])C([H])([H])OC1C([H])=C([H])C(=C([H])C=1[H])C([H])([H])N([H])[C@]([H])(C(N([H])[H])=O)C([H])([H])[H]